Inzoli E, Aroldi A, Piazza R, Gambacorti-Passerini C, et al. Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success. Am J Hematol 2022 Apr 5. doi: 10.1002/ajh.26556.
PMID: 35384030